Négociation Biogaia B - BIOGb CFD

Biogaia is a Sweden-based healthcare company, specialising in probiotics. With 28 years of experience in probiotic products development, Biogaia boasts 440 patents in 32 families and holds a world-leading position on the probiotics market. The company’s products are marketed in more than 100 countries. Its offices can be found in Sweden, the US, and Japan.The Biogaia group effectively runs the following subsidiaries: Biogaia Pharma, Biogaia Biologics, Biogaia Japan, IBT, MetaboGen, TwoPac, and CapAble. Biogaia trades on the NASDAQ Stockholm under the BIOG B ticker. Follow the latest Biogaia share price trends at Capital.com.